Loading clinical trials...
Loading clinical trials...
Advanced Neuroimaging Evaluation of the Central Nervous System Biological Changes Associated With Efavirenz Therapy Switch to an Raltegravir-based Regimen
Conditions
Interventions
Raltegravir
Locations
1
United States
Brigham and Women's hospital
Boston, Massachusetts, United States
Start Date
January 1, 2014
Primary Completion Date
September 1, 2016
Completion Date
January 1, 2017
Last Updated
July 26, 2017
NCT07071623
NCT04929028
NCT01875588
NCT07199335
NCT03087253
NCT05419024
Lead Sponsor
Massachusetts General Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions